Monopar Therapeutics Inc. Common Stock (NASDAQ: MNPR) last traded at $107.72, down 2.85% on the session. The quote above updates while this page is open; the figures below are drawn from Monopar Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Monopar Therapeutics Inc. Common Stock trades on NASDAQ under the ticker MNPR. Its market capitalisation is $723.04 million.
Valuation measures for Monopar Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $723.04M |
|---|---|
| Enterprise value | $674.40M |
| Price / book | 5.53 |
| Beta | 1.55 |
Trailing-twelve-month figures tagged in Monopar Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$17.84M |
| EPS (TTM) | -$2.20 |
| Return on equity | -13.64% |
| Cash | $52.76M |
Range and volume for MNPR over the past 52 weeks.
| 52-week high | $124.82 |
|---|---|
| 52-week low | $29.18 |
| Volume | 176.2K |
| Average volume | 215.5K |
| Previous close | $110.88 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.